FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999910616> ?p ?o ?g. }

• W1999910616 endingPage "1895" @default.
• W1999910616 startingPage "1891" @default.
• W1999910616 abstract "The endothelins (ET) are potent 21-amino-acid vasoconstrictor peptides produced in many different tissues, particularly in the endothelium of blood vessels. ET-1 is the main endothelin secreted by the endothelium, and acts in a paracrine or autocrine fashion on blood vessels by interacting with ETA or ETB receptors on smooth muscle to stimulate contraction or on ETB receptors on endothelial cells to induce the release of vasorelaxants (nitric oxide and prostacyclin). Production of ET-1 is enhanced in several experimental models of hypertension in the rat, such as sodium-sensitive forms, e.g. deoxycorticosterone acetate (DOCA)-salt hypertensive, DOCA-salt-treated spontaneously hypertensive rats (SHR) and Dahl salt-sensitive rats, as well as other models such as stroke-prone SHR, angiotensin II-infused rats and fructose-fed rats, and possibly 1-K 1C Goldblatt hypertensive rats. In contrast, SHR, 2-K 1C Goldblatt hypertensive rats and nitric oxide-deficient (L-NAME-treated) hypertensive rats do not exhibit an ET-1 component. Endothelin dependency is manifested by excessive vascular growth, particularly in small arteries, and blood pressure lowering and regression of vascular growth after treatment with endothelin antagonists. The latter may be combined ETA/ETB or selective ETA antagonists, of which several are orally active and already in clinical development. In humans, endothelin-dependent vascular tone has been shown in studies of forearm blood flow. Enhanced expression of ET-1 mRNA has been demonstrated in the endothelium of small arteries of patients with moderate to severe hypertension. In a 4-week trial the combined ETA/ETB antagonist bosentan reduced the blood pressure of essential hypertensive patients equally to enalapril. Bosentan improved hemodynamics in patients with heart failure in acute and 2-week-long studies. Endothelin antagonists also offer promise in a rapidly fatal condition, primary pulmonary hypertension. Thus, the endothelin system appears to be involved in different forms of cardiovascular disease in experimental animals and humans, and its interruption offers great promise as a new therapeutic intervention in hypertension, heart failure and other diseases." @default.
• W1999910616 created "2016-06-24" @default.
• W1999910616 creator A5046910928 @default.
• W1999910616 date "1998-12-01" @default.
• W1999910616 modified "2023-10-06" @default.
• W1999910616 title "Endothelin and endothelin antagonists in hypertension" @default.
• W1999910616 cites W1522760620 @default.
• W1999910616 cites W1599556324 @default.
• W1999910616 cites W193624571 @default.
• W1999910616 cites W1948194396 @default.
• W1999910616 cites W1965171075 @default.
• W1999910616 cites W1967701704 @default.
• W1999910616 cites W1968826589 @default.
• W1999910616 cites W1972565751 @default.
• W1999910616 cites W1974904913 @default.
• W1999910616 cites W1979604318 @default.
• W1999910616 cites W1980762198 @default.
• W1999910616 cites W1984915952 @default.
• W1999910616 cites W1990134809 @default.
• W1999910616 cites W1992583442 @default.
• W1999910616 cites W1993107044 @default.
• W1999910616 cites W2000004245 @default.
• W1999910616 cites W2002333689 @default.
• W1999910616 cites W2008966495 @default.
• W1999910616 cites W2011048840 @default.
• W1999910616 cites W2012497346 @default.
• W1999910616 cites W2014578041 @default.
• W1999910616 cites W2019472350 @default.
• W1999910616 cites W2020159458 @default.
• W1999910616 cites W2020741324 @default.
• W1999910616 cites W2035047456 @default.
• W1999910616 cites W2043454729 @default.
• W1999910616 cites W2043727115 @default.
• W1999910616 cites W2044261018 @default.
• W1999910616 cites W2045434816 @default.
• W1999910616 cites W2050071705 @default.
• W1999910616 cites W2051285665 @default.
• W1999910616 cites W2056966654 @default.
• W1999910616 cites W2058799403 @default.
• W1999910616 cites W2059369537 @default.
• W1999910616 cites W2064233057 @default.
• W1999910616 cites W2072061985 @default.
• W1999910616 cites W2075075037 @default.
• W1999910616 cites W2080422687 @default.
• W1999910616 cites W2085838621 @default.
• W1999910616 cites W2088505113 @default.
• W1999910616 cites W2088964290 @default.
• W1999910616 cites W2089500756 @default.
• W1999910616 cites W2091581734 @default.
• W1999910616 cites W2093571860 @default.
• W1999910616 cites W2097501580 @default.
• W1999910616 cites W2104840130 @default.
• W1999910616 cites W2105763003 @default.
• W1999910616 cites W2109591901 @default.
• W1999910616 cites W2120863041 @default.
• W1999910616 cites W2130893278 @default.
• W1999910616 cites W2146046550 @default.
• W1999910616 cites W2146098757 @default.
• W1999910616 cites W2148981044 @default.
• W1999910616 cites W2150612536 @default.
• W1999910616 cites W2151869895 @default.
• W1999910616 cites W2156281812 @default.
• W1999910616 cites W2162441695 @default.
• W1999910616 cites W2162804111 @default.
• W1999910616 cites W2249214241 @default.
• W1999910616 cites W2333143411 @default.
• W1999910616 cites W2333910906 @default.
• W1999910616 cites W2336208433 @default.
• W1999910616 cites W2336346210 @default.
• W1999910616 cites W2395791968 @default.
• W1999910616 cites W2408956519 @default.
• W1999910616 cites W2409954446 @default.
• W1999910616 cites W2434783289 @default.
• W1999910616 doi "https://doi.org/10.1097/00004872-199816121-00007" @default.
• W1999910616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9886874" @default.
• W1999910616 hasPublicationYear "1998" @default.
• W1999910616 type Work @default.
• W1999910616 sameAs 1999910616 @default.
• W1999910616 citedByCount "92" @default.
• W1999910616 countsByYear W19999106162012 @default.
• W1999910616 countsByYear W19999106162013 @default.
• W1999910616 countsByYear W19999106162014 @default.
• W1999910616 countsByYear W19999106162015 @default.
• W1999910616 countsByYear W19999106162017 @default.
• W1999910616 countsByYear W19999106162018 @default.
• W1999910616 countsByYear W19999106162019 @default.
• W1999910616 countsByYear W19999106162021 @default.
• W1999910616 countsByYear W19999106162022 @default.
• W1999910616 crossrefType "journal-article" @default.
• W1999910616 hasAuthorship W1999910616A5046910928 @default.
• W1999910616 hasConcept C126322002 @default.
• W1999910616 hasConcept C128240485 @default.
• W1999910616 hasConcept C134018914 @default.
• W1999910616 hasConcept C144980905 @default.
• W1999910616 hasConcept C149601957 @default.
• W1999910616 hasConcept C170493617 @default.
• W1999910616 hasConcept C2776992346 @default.
• W1999910616 hasConcept C2779395532 @default.

• next